167 related articles for article (PubMed ID: 26424779)
1. Prevalence and Predictors of Inappropriate Delivery of Palliative Thoracic Radiotherapy for Metastatic Lung Cancer.
Koshy M; Malik R; Mahmood U; Husain Z; Weichselbaum RR; Sher DJ
J Natl Cancer Inst; 2015 Dec; 107(12):djv278. PubMed ID: 26424779
[TBL] [Abstract][Full Text] [Related]
2. Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study.
Chen AB; Cronin A; Weeks JC; Chrischilles EA; Malin J; Hayman JA; Schrag D
J Clin Oncol; 2013 Feb; 31(5):558-64. PubMed ID: 23295799
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and predictors of neoadjuvant therapy for stage IIIA non-small cell lung cancer in the National Cancer Database: importance of socioeconomic status and treating institution.
Sher DJ; Liptay MJ; Fidler MJ
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):303-12. PubMed ID: 24685443
[TBL] [Abstract][Full Text] [Related]
4. Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.
Stevens R; Macbeth F; Toy E; Coles B; Lester JF
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD002143. PubMed ID: 25586198
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated vs. conventional radiation therapy for stage III non-small cell lung cancer treated without chemotherapy.
Iocolano M; Wild AT; Hannum M; Zhang Z; Simone CB; Gelblum D; Wu AJ; Rimner A; Shepherd AF
Acta Oncol; 2020 Feb; 59(2):164-170. PubMed ID: 31608751
[No Abstract] [Full Text] [Related]
6. Risk factors for esophagitis after hypofractionated palliative (chemo) radiotherapy for non-small cell lung cancer.
Nieder C; Imingen KS; Mannsåker B; Yobuta R; Haukland E
Radiat Oncol; 2020 May; 15(1):91. PubMed ID: 32357936
[TBL] [Abstract][Full Text] [Related]
7. The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic Diseases.
Chiang Y; Yang JC; Hsu FM; Chen YH; Shih JY; Lin ZZ; Lan KH; Cheng AL; Kuo SH
PLoS One; 2015; 10(12):e0145936. PubMed ID: 26720170
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
[TBL] [Abstract][Full Text] [Related]
9. RE: Prevalence and Predictors of Inappropriate Delivery of Palliative Thoracic Radiotherapy for Metastatic Lung Cancer.
Schild SE; Ashman JB; Keole SR; Daniels TB; Rule WG
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26744478
[No Abstract] [Full Text] [Related]
10. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
11. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
Sher DJ; Koshy M; Liptay MJ; Fidler MJ
Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of aggressive thoracic radiation therapy and concurrent chemoradiation therapy in metastatic lung cancer.
Koshy M; Malik R; Mahmood U; Rusthoven CG; Sher DJ
Pract Radiat Oncol; 2015; 5(6):374-82. PubMed ID: 26412340
[TBL] [Abstract][Full Text] [Related]
13. Survival and prognostic factors after moderately hypofractionated palliative thoracic radiotherapy for non-small cell lung cancer.
van Oorschot B; Assenbrunner B; Schuler M; Beckmann G; Flentje M
Strahlenther Onkol; 2014 Mar; 190(3):270-5. PubMed ID: 24413894
[TBL] [Abstract][Full Text] [Related]
14. Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial.
Falk SJ; Girling DJ; White RJ; Hopwood P; Harvey A; Qian W; Stephens RJ;
BMJ; 2002 Aug; 325(7362):465. PubMed ID: 12202326
[TBL] [Abstract][Full Text] [Related]
15. Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study.
Haslett K; Bayman N; Franks K; Groom N; Harden SV; Harris C; Hanna G; Harrow S; Hatton M; McCloskey P; McDonald F; Ryder WD; Faivre-Finn C
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1341-1348. PubMed ID: 33232772
[TBL] [Abstract][Full Text] [Related]
16. Safety and palliative efficacy of single-dose 8-Gy reirradiation for painful local failure in patients with stage IV non-small cell lung cancer previously treated with radical chemoradiation therapy.
Topkan E; Yildirim BA; Guler OC; Parlak C; Pehlivan B; Selek U
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):774-80. PubMed ID: 25752391
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival in patients with non-small cell lung cancer treated with palliative radiotherapy.
Quddus AM; Kerr GR; Price A; Gregor A
Clin Oncol (R Coll Radiol); 2001; 13(2):95-8. PubMed ID: 11373887
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of radiation therapy alone for elderly patients with unresected stage III non-small cell lung cancer.
Sigel K; Lurslurchachai L; Bonomi M; Mhango G; Bergamo C; Kale M; Halm E; Wisnivesky J
Lung Cancer; 2013 Nov; 82(2):266-70. PubMed ID: 24011407
[TBL] [Abstract][Full Text] [Related]
19. Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.
Ahmed HZ; Liu Y; O'Connell K; Ahmed MZ; Cassidy RJ; Gillespie TW; Patel P; Pillai RN; Behera M; Steuer CE; Owonikoko TK; Ramalingam SS; Curran WJ; Higgins KA
Clin Lung Cancer; 2017 Nov; 18(6):706-718. PubMed ID: 28601387
[TBL] [Abstract][Full Text] [Related]
20. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
van den Hout WB; Kramer GW; Noordijk EM; Leer JW
J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]